ALEXANDER H.R., FRAKER D.L, NORTON J.A., BARTLETT D.L., TIO L., BENJAMIN S.B., DOPPMAN J.L., GOEBEL S.U., SERRANO J., GIBRIL F. & R.T.JENSEN, 1998: Prospective Study of Somatostatin Receptor Scintigraphy and its Effect on Operative Outcome in Patients With Zollinger-Ellison Syndrome: Annals of Surgery, Vol. 228(2), 228-238.

GIBRIL F., DOPPMAN J.L, REYNOLDS J.C., CHEN C., SUTLIFF V.E., YU F., SERRANO J., VENZON D.J & R.T.JENSEN, 1998: Bone Metastasis in Patients with Gastrinomas: A Prospective Study of Bone Scanning, Somatostatine Receptor scanning, and Magnetic Resonance image in Their Detection, Frequency, Location nad Effect of Their Detection on Management. Journal of Clinical Oncology, Vol. 16 (3), pp. 1040-1053.

GIBRIL F., REYNOLDS J.C., DOPPMAN J.L, CHEN C., VENZON D.J, TERMANINI B., WEBER C., STEWART C.A & R.T.JENSEN, 1996: Somatostatin Receptor Scintigraphy: Its Sensitivity Compared with That of other Imaging Methods in Detecting Primary and Metastatic Gastrinomas. A Prospective Study. Annals of Internal Medicine, Vol. 125 (1), pp. 26-34.

GIBRIL F., REYNOLDS J.C., LUBENSKY I.A., ROY P.K., PEGHINI P.L., DOPMANN J.L. & R.T.JENSEN, 2000: Ability of Somatostatin Receptor Scintigraphy to Identify Patients with Gastric Carcinoids: A Prospective Study. Journal of Nuclear Medicine, Vol. 41 (10), pp. 1646-1656.

GIBRIL F., REYNOLDS J.C., CHEN C., YU F., GOEBEL S.U., SERRANO J., DOPMANN J.L. & R.T.JENSEN, 1998: Specifity of Somatostatin Receptor Scintigraphy: A Prospective study and Effects of False-Positive Localisations on Management in patients with Gastrinomas. Journal of Nuclear Medicine, Vol. 40 (4), pp. 539-553.

KRENNING E.P., KWEKKEBOOM D.J., BAKKER W.H., BREEMAN W.A.P., KOOIJ P.P.M, OEI H.Y., van HAGEN M., POSTEMA P.T.A., de JONG M., REUBI J.C., VISSER T.J, REIJS T.J., HOFLAND L.J., KOPER J.W. & S.W.J. LAMBERT, 1993: Somatostatin receptor scintigraphy with [¹¹¹In-DTPA-_D-Phe¹]- and [¹²³I-Tyr³]-octreotide: the Rotterdam experience with more than 1000 patients. European Journal of Nuclear Medicine, Vol 20., pp. 716-731.

KRENNING E.P., KWEKKEBOOM D.J., OEI H.Y., de JONG M., DOP F.J., REUBI J.C. & S.W.J. LAMBERT: Somatostatin receptor Scintigraphy in Gastroenteropancreatic Tumors: An Overwiev of European Results. Annals New-York Academy of Sciences, pp. 416-424.

KRENNING E.P., de JONG M., KOOIJ P.P.M, BREEMAN W.A.P., BAKKER W.H., de HERDER W.W., van EIJCK C.H.J., KWEKKEBOOM D.J., JAMAR J, PAUWELS S. & R. VALKEMA, 1999: Radiolabelled somastostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy. Annals of Oncology, Vol. 10, pp. 23-29.

KWEKKEBOOM D.J., HOFF A.M., LAMBERTS S.W.J., OEI H.Y & E.P. KRENNING, 1992: Somatostatin Analogue Scintigraphy: A Simple and Sensitive Method for the In Vivo Visualisation of Merkell Cell Tumors and Their Metastases. Arch. Dermatol., Vol. 128, pp.818-821.

LUGTENBURG P.J., KRENNING E.P., VALKEMA R., OEI H.Y, LAMBERTS S.W.J. EIJKMANS M.J.C., van PUTTEN W.L.J. & B. LÖWENBERG, 2001: Somatostatin Receptor Scintigraphy Useful in Stage I-II Hodgkins disease: more extended disease identified. British Journal of Haematology, Vol. 112, pp. 936-944.

LUGTENBURG P.J.,  LÖWENBERG B., VALKEMA R., OEI H.Y, LAMBERTS S.W.J., EIJKMANS M.J.C., van PUTTEN W.L.J.  & E.P. KRENNING E.P., 2001: Somatostatin Receptor Scintigraphy in the initial Staging of Low-Grade Non-Hodgkins Lymphomas. Journal of Nuclear Medicine, Vol. 42 (2), pp. 222-229.

PROYE C., MALVAUX P., PATTOU F., FILOCHE B., GODCHAUC J.-M., V. MAUNOURY, PALAZZO L., HUGLO D., LEFEBVRE J. & J.-C. PARIS, 1998: Noninvasive Imaging of Insulinomas and Gastrinomas with Endoscopic Ultrasonography and Somatostatin Receptor Scintigraphy. Proccedings of 19-th Meeting of American Association of Endocrine Surgeons. 

JAMAR F., FIASSE R., LENERS N. & S. PAUWELS, 1994: Somatostatin Receptor Imaging with Indium-111-Pentetreotide in Gastroenteropancreatic neuroendocrine Tumors: Safety, Efficacy and Impact on Patient Management. Journal of Nuclear Medicine, Vol. 36 (4), pp. 542-549.

GARIN E., DEVILLIERS A., Le CLOIREC L., BERNARD A.M, LESCOUARCH J., HERRY J.Y., REUBI J.C. & P. BOURGUET, 1998: Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake. European Journal of Nuclear Medicine, Vol. 25(7), pp. 687-694.

SCHILLACI O., CORLETO V.D., ANNIBALE B., SCOPINARO F. & G. DELLE FAVE, 1999: Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours. Italian Journal of Gastroenterol. and Hepatol., Vol. 31 (2), pp- 186-189.

SCHMIDT M., SCHEIDHAUER K., LUYKEN C., VOTH E., HILDEBRANDT G., KLUG N. & H. SCHICHA, 1998: Somatostatin Receptor imaging in Intracranial Tumours. European Journal of Nuclear Medicine, Vol. 25 (7), pp 675-686.

SLOOTER G.D., MEARADJI A., BREEMAN W.A.P., MARQUET R.LO., de JONG M., KRENNING E.P. & C.H.J. van EIJCK, 2001: Somatostatin Receptor Imaging, therapy and new strategies in patients with neuroendocrine tumours. British Journal of  Surgery, Vol. 88, pp. 31-40.   

TERMANINI B., GIBRIL F., DOPPMAN J.L, REYNOLDS J.C., STEWART C.A.,  SUTLIFF V.E., VENZON D.J & R.T. JENSEN, 1997: Distuingushing Small Hepatic Hemangiomas from Vascular Liver Metastases in Gastrinoma: Use of a Somatostatin-Receptor Scintigraphic Agent. Radiology, Vol. 202, pp. 151-158.

TERMANINI B., GIBRIL F., REYNOLDS J.C., DOPPMAN J.L, CHEN C.C., STEWART C.A.,  SUTLIFF V.E. & R.T. JENSEN, 1997: Value of Somatostatin Receptor Scintigraphy: A Prospective Study in Gastrinoma of its Effect on Clinical Management. Gastroenterology, Vol. 112: 335-347.

Pokud byste měli o některou z těchto prací zájem, kontaktujte nás e-mailem nebo telefonicky.

Vytištěno z www stránek firmy KC SOLID, spol. s r.o.
www.kcsolid.cz